Metformin reverse minocycline to inhibit minocycline-resistant Acinetobacter baumannii by destroy the outer membrane and enhance membrane potential in vitro

Brown ED, Wright GD. Antibacterial drug discovery in the resistance era. Nature. 2016;529(7586):336–43.

CAS  PubMed  Article  Google Scholar 

Tyumentseva M, Mikhaylova Y, Prelovskaya A, Tyumentsev A, Petrova L, Fomina V, Zamyatin M, Shelenkov A, Akimkin V. Genomic and Phenotypic Analysis of Multidrug-Resistant Acinetobacter baumannii Clinical Isolates Carrying Different Types of CRISPR/Cas Systems. Pathogens (Basel, Switzerland). 2021;10(2):205.

CAS  Google Scholar 

Hamidian M, Nigro SJ. Emergence, molecular mechanisms and global spread of carbapenem-resistant Acinetobacter baumannii. Microb Genom. 2019;5(10):e000306.

PubMed Central  Google Scholar 

Fragkou PC, Poulakou G, Blizou A, Blizou M, Rapti V, Karageorgopoulos DE, Koulenti D, Papadopoulos A, Matthaiou DK, Tsiodras S. The Role of Minocycline in the Treatment of Nosocomial Infections Caused by Multidrug, Extensively Drug and Pandrug Resistant Acinetobacter baumannii: A Systematic Review of Clinical Evidence. Microorganisms. 2019;7(6):159.

CAS  PubMed Central  Article  Google Scholar 

Goff DA, Bauer KA, Mangino JE. Bad bugs need old drugs: a stewardship program’s evaluation of minocycline for multidrug-resistant Acinetobacter baumannii infections. Clin Infect Dis. 2014;59(Suppl 6):S381-387.

CAS  PubMed  Article  Google Scholar 

Bowers DR, Cao H, Zhou J, Ledesma KR, Sun D, Lomovskaya O, Tam VH. Assessment of minocycline and polymyxin B combination against Acinetobacter baumannii. Antimicrob Agents Chemother. 2015;59(5):2720–5.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Asadi A, Abdi M, Kouhsari E, Panahi P, Sholeh M, Sadeghifard N, Amiriani T, Ahmadi A, Maleki A, Gholami M. Minocycline, focus on mechanisms of resistance, antibacterial activity, and clinical effectiveness: back to the future. J Glob Antimicrob Resist. 2020;22:161–74.

PubMed  Article  Google Scholar 

Sapadin AN, Fleischmajer R. Tetracyclines: nonantibiotic properties and their clinical implications. J Am Acad Dermatol. 2006;54(2):258–65.

PubMed  Article  Google Scholar 

Castanheira M, Mendes RE, Jones RN. Update on Acinetobacter species: mechanisms of antimicrobial resistance and contemporary in vitro activity of minocycline and other treatment options. Clin Infect Dis. 2014;59(Suppl 6):S367-373.

CAS  PubMed  Article  Google Scholar 

Tarazi Z, Sabet M, Dudley MN, Griffith DC. Pharmacodynamics of Minocycline against Acinetobacter baumannii in a Rat Pneumonia Model. Antimicrobial Agents Chemother. 2019;63(2):e01671-18.

CAS  Article  Google Scholar 

Nagasawa T, Arai M, Togari A. Inhibitory effect of minocycline on osteoclastogenesis in mouse bone marrow cells. Arch Oral Biol. 2011;56(9):924–31.

CAS  PubMed  Article  Google Scholar 

Thompson KG, Rainer BM, Antonescu C, Florea L, Mongodin EF, Kang S, Chien AL. Minocycline and Its Impact on Microbial Dysbiosis in the Skin and Gastrointestinal Tract of Acne Patients. Ann Dermatol. 2020;32(1):21–30.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Kuo SC, Chang SC, Wang HY, Lai JF, Chen PC, Shiau YR, Huang IW, Lauderdale TL. Emergence of extensively drug-resistant Acinetobacter baumannii complex over 10 years: nationwide data from the Taiwan Surveillance of Antimicrobial Resistance (TSAR) program. BMC Infect Dis. 2012;12:200.

PubMed  PubMed Central  Article  Google Scholar 

Wright GD. Antibiotic Adjuvants: Rescuing Antibiotics from Resistance. Trends Microbiol. 2016;24(11):862–71.

CAS  PubMed  Article  Google Scholar 

King AM, Reid-Yu SA, Wang W, King DT, De Pascale G, Strynadka NC, Walsh TR, Coombes BK, Wright GD. Aspergillomarasmine A overcomes metallo-β-lactamase antibiotic resistance. Nature. 2014;510(7506):503–6.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Tian J, Zhang J, Yang J, Du L, Geng H, Cheng Y. Conjugated Polymers Act Synergistically with Antibiotics to Combat Bacterial Drug Resistance. ACS Appl Mater Interfaces. 2017;9(22):18512–20.

CAS  PubMed  Article  Google Scholar 

Sanchez-Rangel E, Inzucchi SE. Metformin: clinical use in type 2 diabetes. Diabetologia. 2017;60(9):1586–93.

CAS  PubMed  Article  Google Scholar 

Pernicova I, Korbonits M. Metformin–mode of action and clinical implications for diabetes and cancer. Nat Rev Endocrinol. 2014;10(3):143–56.

CAS  PubMed  Article  Google Scholar 

Siavash M, Tabbakhian M, Sabzghabaee AM, Razavi N. Severity of Gastrointestinal Side Effects of Metformin Tablet Compared to Metformin Capsule in Type 2 Diabetes Mellitus Patients. Journal of research in pharmacy practice. 2017;6(2):73–6.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Vallianou NG, Stratigou T, Tsagarakis S. Metformin and gut microbiota: their interactions and their impact on diabetes. Hormones. 2019;18(2):141–4.

PubMed  Article  Google Scholar 

Kim E, Kim AH, Lee Y, Ji SC, Cho JY, Yu KS, Chung JY. Effects of vancomycin-induced gut microbiome alteration on the pharmacodynamics of metformin in healthy male subjects. Clin Transl Sci. 2021;14(5):1955–66.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Podhorecka M, Ibanez B, Dmoszyńska A. Metformin - its potential anti-cancer and anti-aging effects. Postepy Hig Med Dosw(Online). 2017;71:170–5.

Google Scholar 

Shih CJ, Wu YL, Chao PW, Kuo SC, Yang CY, Li SY, Ou SM, Chen YT. Association between Use of Oral Anti-Diabetic Drugs and the Risk of Sepsis: A Nested Case-Control Study. Sci Rep. 2015;5:15260.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Mor A, Petersen I, Sørensen HT, Thomsen RW. Metformin and other glucose-lowering drug initiation and rates of community-based antibiotic use and hospital-treated infections in patients with type 2 diabetes: a Danish nationwide population-based cohort study. BMJ Open. 2016;6(8):e011523.

PubMed  PubMed Central  Article  Google Scholar 

Singhal A, Jie L, Kumar P, Hong GS, Leow MK, Paleja B, Tsenova L, Kurepina N, Chen J, Zolezzi F, et al. Metformin as adjunct antituberculosis therapy. Sci Transl Med. 2014;6(263):263ra159.

PubMed  Article  CAS  Google Scholar 

Liu Y, Jia Y, Yang K, Li R, Xiao X, Zhu K, Wang Z. Metformin Restores Tetracyclines Susceptibility against Multidrug Resistant Bacteria. Adv Sci (Weinheim, Baden-Wurttemberg, Germany. 2020;7(12):1902227.

CAS  Google Scholar 

Hegazy WAH, Khayat MT, Ibrahim TS, Nassar MS, Bakhrebah MA, Abdulaal WH, Alhakamy NA, Bendary MM. Repurposing Anti-diabetic Drugs to Cripple Quorum Sensing in Pseudomonas aeruginosa. Microorganisms. 2020;8(9):1285.

CAS  PubMed Central  Article  Google Scholar 

Wang YC, Huang TW, Yang YS, Kuo SC, Chen CT, Liu CP, Liu YM, Chen TL, Chang FY, Wu SH, et al. Biofilm formation is not associated with worse outcome in Acinetobacter baumannii bacteraemic pneumonia. Sci Rep. 2018;8(1):7289.

PubMed  PubMed Central  Article  CAS  Google Scholar 

Bardbari AM, Arabestani MR, Karami M, Keramat F, Aghazadeh H, Alikhani MY, Bagheri KP. Highly synergistic activity of melittin with imipenem and colistin in biofilm inhibition against multidrug-resistant strong biofilm producer strains of Acinetobacter baumannii. Euro J Clin Microbiol Infect Dis. 2018;37(3):443–54.

CAS  Article  Google Scholar 

Dwyer DJ, Belenky PA, Yang JH, MacDonald IC, Martell JD, Takahashi N, Chan CT, Lobritz MA, Braff D, Schwarz EG, et al. Antibiotics induce redox-related physiological alterations as part of their lethality. Proc Natl Acad Sci USA. 2014;111(20):E2100-2109.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Liu Y, Shi J, Tong Z, Jia Y, Yang K, Wang Z. Potent Broad-Spectrum Antibacterial Activity of Amphiphilic Peptides against Multidrug-Resistant Bacteria. Microorganisms. 2020;8(9):1398.

CAS  PubMed Central  Article  Google Scholar 

Dijkshoorn L, Nemec A, Seifert H. An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat Rev Microbiol. 2007;5(12):939–51.

CAS  PubMed  Article  Google Scholar 

Opazo A, Domínguez M, Bello H, Amyes SG, González-Rocha G. OXA-type carbapenemases in Acinetobacter baumannii in South America. J Infect Dev Ctries. 2012;6(4):311–6.

PubMed  Article  Google Scholar 

Gootz TD, Marra A. Acinetobacter baumannii: an emerging multidrug-resistant threat. Expert Rev Anti Infect Ther. 2008;6(3):309–25.

CAS  PubMed  Article  Google Scholar 

Gaurav A, Gupta V, Shrivastava SK, Pathania R. Mechanistic insights into synergy between nalidixic acid and tetracycline against clinical isolates of Acinetobacter baumannii and Escherichia coli. Commun Biol. 2021;4(1):542.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Shin B, Park W. Synergistic Effect of Oleanolic Acid on Aminoglycoside Antibiotics against Acinetobacter baumannii. PLoS One. 2015;10(9):e0137751.

PubMed  PubMed Central  Article  CAS  Google Scholar 

Lv Z, Guo Y. Metformin and Its Benefits for Various Diseases. Front Endocrinol. 2020;11:191.

Article  Google Scholar 

Vancura A, Bu P, Bhagwat M, Zeng J, Vancurova I. Metformin as an Anticancer Agent. Trends Pharmacol Sci. 2018;39(10):867–78.

CAS 

留言 (0)

沒有登入
gif